Quick Answer
NeuroPace Inc reported Cash And Cash Equivalents At Carrying Value of $21.69 million for the year ending 2025.
- NeuroPace Inc showed an increase of +61.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from NeuroPace Inc's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), NeuroPace Inc's Cash And Cash Equivalents At Carrying Value has declined by 17.8%.
- Historical annual values: Fiscal year 2025: $21.69 million | Fiscal year 2024: $13.43 million | Fiscal year 2023: $18.06 million | Fiscal year 2022: $6.61 million | Fiscal year 2021: $19.19 million | Fiscal year 2020: $26.39 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: